Biogen (BIIB) Inventory Average (2009 - 2026)
Biogen (BIIB) posted quarterly Inventory Average of $2.2 billion for Q2 2026, down 4.72% year-over-year from $2.3 billion in Q2 2025, and up 5.25% quarter-over-quarter from $2.1 billion in Q1 2026.
Biogen (BIIB) Inventory Average (2009 - 2026) Analysis & Trends
Biogen's Inventory Average history runs 18 years deep, the most recent figure standing at $2.2 billion for Q2 2026.
- In Q2 2026, Inventory Average fell 4.72% year-over-year to $2.2 billion; the TTM figure through Jun 2026 stood at $2.2 billion (down 4.72% YoY), while the FY2025 annual figure was $2.3 billion, down 7.2% from the prior year.
- Inventory Average for Q2 2026 stood at $2.2 billion, up from $2.1 billion in the prior quarter.
- The five-year high for Inventory Average was $2.8 billion in Q4 2023, with the low at $1.3 billion in Q2 2022.
- The 5-year median for Inventory Average is $2.2 billion (2025), against an average of $2.0 billion.
- The sharpest annual moves came in 2023 and 2026: Inventory Average soared 102.61% in 2023, then declined 13.04% in 2026.
- Biogen's Inventory Average stood at $1.4 billion in 2022, then soared by 102.61% to $2.8 billion in 2023, then decreased by 10.53% to $2.5 billion in 2024, then retreated by 11.2% to $2.2 billion in 2025, then declined by 1.01% to $2.2 billion in 2026.
- Business Quant data shows BIIB's Inventory Average at $2.2 billion in Q2 2026, $2.1 billion in Q1 2026, and $2.2 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 6.75 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 6.20 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.93 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 10.31 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 8.36 Bn |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn | 2.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.17 Bn |
| Mar 31, 2026 | 2.06 Bn |
| Dec 31, 2025 | 2.19 Bn |
| Sep 30, 2025 | 2.24 Bn |
| Jun 30, 2025 | 2.27 Bn |
| Mar 31, 2025 | 2.37 Bn |
| Dec 31, 2024 | 2.46 Bn |
| Sep 30, 2024 | 2.49 Bn |
| Jun 30, 2024 | 2.51 Bn |
| Mar 31, 2024 | 2.52 Bn |
| Dec 31, 2023 | 2.75 Bn |
| Sep 30, 2023 | 2.16 Bn |
| Jun 30, 2023 | 1.31 Bn |
| Mar 31, 2023 | 1.31 Bn |
| Dec 31, 2022 | 1.36 Bn |
| Sep 30, 2022 | 1.33 Bn |
| Jun 30, 2022 | 1.25 Bn |
| Mar 31, 2022 | 1.28 Bn |
| Dec 31, 2021 | 1.35 Bn |
| Sep 30, 2021 | 1.30 Bn |